Course fees and academic ranking: insights from the IMI EMTRAIN on-course® database

Drug Discov Today. 2014 Jul;19(7):830-3. doi: 10.1016/j.drudis.2013.12.001. Epub 2013 Dec 8.

Abstract

The Innovative Medicines Initiative (IMI) funded project on-course® (http://www.on-course.eu/) lists postgraduate biomedical courses in Europe and is comprehensive for all taught and research master's courses. Using on-course®, new insights into education and training in Europe can be delivered; and here we investigate the relationship between master's course fees and university ranking. We hypothesise that higher master's course fees would be associated with higher university ranking. This was indeed the case for research master's courses and for taught master's courses for non-EU students. However, we observed no correlation between taught master's course fees for EU students and university ranking, meaning EU students are paying on average as much for courses at lower ranked universities as they are for courses at higher ranked universities.

Publication types

  • Review

MeSH terms

  • Curriculum / standards*
  • Databases, Factual*
  • Drug Industry / economics
  • Drug Industry / standards
  • European Union*
  • Humans
  • Universities / economics*
  • Universities / standards*